HomeCompareATNF vs PLD

ATNF vs PLD: Dividend Comparison 2026

ATNF yields 28.41% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.79M in total portfolio value· pulled ahead in Year 7
10 years
ATNF
ATNF
● Live price
28.41%
Share price
$7.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$120.7K
Annual income
$15,231.92
Full ATNF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — ATNF vs PLD

📍 PLD pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATNFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATNF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ATNF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATNF
Annual income on $10K today (after 15% tax)
$2,414.77/yr
After 10yr DRIP, annual income (after tax)
$12,947.13/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $4,025,169.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATNF + PLD for your $10,000?

ATNF: 50%PLD: 50%
100% PLD50/50100% ATNF
Portfolio after 10yr
$3.01M
Annual income
$2,382,978.55/yr
Blended yield
79.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

ATNF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
-2.9
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATNF buys
0
PLD buys
0
No recent congressional trades found for ATNF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATNFPLD
Forward yield28.41%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$120.7K$5.91M
Annual income after 10y$15,231.92$4,750,725.19
Total dividends collected$80.6K$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: ATNF vs PLD ($10,000, DRIP)

YearATNF PortfolioATNF Income/yrPLD PortfolioPLD Income/yrGap
1$13,541$2,840.91$11,241$540.96+$2.3KATNF
2$18,084$3,595.19$13,019$991.13+$5.1KATNF
3$23,837$4,487.28$15,801$1,870.97+$8.0KATNF
4$31,034$5,527.89$20,609$3,701.21+$10.4KATNF
5$39,932$6,725.96$29,919$7,867.97+$10.0KATNF
6$50,815$8,088.33$50,631$18,617.74+$184.00ATNF
7← crossover$63,992$9,619.46$105,528$51,352.20$41.5KPLD
8$79,793$11,321.31$287,364$174,449.42$207.6KPLD
9$98,572$13,193.22$1,081,760$774,280.77$983.2KPLD
10$120,703$15,231.92$5,908,209$4,750,725.19$5.79MPLD

ATNF vs PLD: Complete Analysis 2026

ATNFStock

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

Full ATNF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this ATNF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATNF vs SCHDATNF vs JEPIATNF vs OATNF vs KOATNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.